Numerous studies have investigated the role of PKM2 in the progression of chronic liver diseases, including liver fibrosis (Rao et al., 2022), fatty liver diseases (Dong et al., 2024) and even liver cancers (Hou et al., 2020). This evidence concerns the gene PKM and Hepatic fibrosis.